Cargando…

Resequencing to Fine Map Known Idiopathic Pulmonary Fibrosis Risk Genes. Homing in on Causal Variants

Detalles Bibliográficos
Autores principales:	Allen, Richard, Ortega, Victor E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2019
Materias:	Editorials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6635787/ https://www.ncbi.nlm.nih.gov/pubmed/31113211 http://dx.doi.org/10.1164/rccm.201905-0925ED

Ejemplares similares

Autophagy in Idiopathic Pulmonary Fibrosis: Predisposition of the Aging Lung to Fibrosis?
por: Zmijewski, Jaroslaw W., et al.
Publicado: (2022)

Remote Monitoring in Idiopathic Pulmonary Fibrosis: Home Is Where the Bluetooth-enabled Spirometer Is
por: Johannson, Kerri A.
Publicado: (2020)

Assessing the Burden and Prognostic Value of Cough in Idiopathic Pulmonary Fibrosis
por: Johnston, Janet, et al.
Publicado: (2023)

Defining the Genetic Landscape of Idiopathic Pulmonary Fibrosis: Role of Common and Rare Variants
por: Moss, Benjamin J., et al.
Publicado: (2023)

Genetic and Epigenetic Fine-Mapping of Causal Autoimmune Disease Variants
por: Farh, Kyle Kai-How, et al.
Publicado: (2014)

Identifying causal variants by fine mapping across multiple studies
por: LaPierre, Nathan, et al.
Publicado: (2021)

Proportion of Idiopathic Pulmonary Fibrosis Risk Explained by Known Common Genetic Loci in European Populations
por: Leavy, Olivia C., et al.
Publicado: (2021)

Idiopathic pulmonary fibrosis: moving forward
por: Richeldi, Luca
Publicado: (2015)

State of the Art in Idiopathic Pulmonary Fibrosis
por: El Agha, Elie, et al.
Publicado: (2022)

Toward Early Detection of Idiopathic Pulmonary Fibrosis
por: Schupp, Jonas Christian, et al.
Publicado: (2019)

Idiopathic pulmonary fibrosis management: caring is sparing
por: Nava, Stefano, et al.
Publicado: (2020)

ATP12A: Connecting Mucus and Fibrosis in Idiopathic Pulmonary Fibrosis
por: Zabner, Joseph, et al.
Publicado: (2023)

Mapping brain endophenotypes associated with idiopathic pulmonary fibrosis genetic risk
por: Mohammadi-Nejad, Ali-Reza, et al.
Publicado: (2022)

Integrating Functional Data to Prioritize Causal Variants in Statistical Fine-Mapping Studies
por: Kichaev, Gleb, et al.
Publicado: (2014)

Fine-mapping of Parkinson’s disease susceptibility loci identifies putative causal variants
por: Schilder, Brian M, et al.
Publicado: (2021)

Guidelines or guidance for better idiopathic pulmonary fibrosis management?
por: Behr, Jürgen
Publicado: (2016)

Ironing Out the Roles of Macrophages in Idiopathic Pulmonary Fibrosis
por: O’Dwyer, David N., et al.
Publicado: (2019)

Another Weapon in the Battle against Idiopathic Pulmonary Fibrosis?
por: Wilson, Carole L., et al.
Publicado: (2019)

Idiopathic pulmonary fibrosis: accurate diagnosis and early treatment
por: Morais, António
Publicado: (2019)

Small Airways in Idiopathic Pulmonary Fibrosis: Quiet but Not Forgotten
por: Maher, Toby M.
Publicado: (2021)

Chronic Cough in Idiopathic Pulmonary Fibrosis: The Same Difference?
por: Morice, Alyn H.
Publicado: (2022)

Novel idiopathic pulmonary fibrosis susceptibility variants revealed by deep sequencing
por: Lorenzo-Salazar, Jose M., et al.
Publicado: (2019)

Mendelian randomisation highlights hypothyroidism as a causal determinant of idiopathic pulmonary fibrosis
por: Zhang, Yanan, et al.
Publicado: (2021)

Application of Bayesian network structure learning to identify causal variant SNPs from resequencing data
por: Schlosberg, Christopher E, et al.
Publicado: (2011)

Idiopathic pulmonary fibrosis in Brazil: challenges for epidemiological characterization and management
por: Baldi, Bruno Guedes
Publicado: (2017)

Six-minute walk test in patients with idiopathic pulmonary fibrosis
por: Baddini-Martinez, José Antônio
Publicado: (2018)

Registries for Idiopathic Pulmonary Fibrosis: When Is It Time to Go Global?
por: Funke-Chambour, Manuela
Publicado: (2020)

Evolvement of best practice in diagnosis and management of idiopathic pulmonary fibrosis
por: Poletti, Venerino
Publicado: (2014)

On Target: CYFRA 21-1 as an Idiopathic Pulmonary Fibrosis Biomarker
por: Spagnolo, Paolo, et al.
Publicado: (2022)

Updates in the New Guidelines for Idiopathic Pulmonary Fibrosis: Role of Cryobiopsy
por: Cascante Rodrigo, Jose Antonio, et al.
Publicado: (2022)

Effect of home-based pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis
por: Ozalevli, Sevgi, et al.
Publicado: (2010)

An Overview of Canine Inherited Neurological Disorders with Known Causal Variants
por: Cocostîrc, Vlad, et al.
Publicado: (2023)

Fine Mapping and Whole-Genome Resequencing Identify the Seed Coat Color Gene in Brassica rapa
por: Wang, Yanhua, et al.
Publicado: (2016)

SARS-CoV-2 variants of concern: the knowns and unknowns
por: Lessells, Richard J.
Publicado: (2021)

Genetic Susceptibility to Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis: The Missing Link?
por: Polverino, Francesca
Publicado: (2023)

Using Families to Study Pulmonary Fibrosis Genetics
por: Allen, Richard J.
Publicado: (2023)

Telomere Shortening Is behind the Harm of Immunosuppressive Therapy in Idiopathic Pulmonary Fibrosis
por: Molina-Molina, Maria
Publicado: (2019)

Lost in Translation: Endoplasmic Reticulum–Mitochondria Crosstalk in Idiopathic Pulmonary Fibrosis
por: Bueno, Marta, et al.
Publicado: (2020)

Idiopathic Pulmonary Fibrosis and Lung Cancer: Finding Similarities within Differences
por: Reyfman, Paul A., et al.
Publicado: (2019)

The Role of Surgical Lung Biopsy in Antifibrotic Therapy for Idiopathic Pulmonary Fibrosis
por: Limper, Andrew H.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_8u22utso34f2mt7esoel4ml85e